Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cross Country HealthcareFRA:XXY 56 Buyback Yield % is 1.37 as of Jul. 25, 2026, which is 63% below its 10-year median of 3.67. GuruFocus rates FRA:XXY with a GF Score™ of 56/100 and a GF Value™ of €9.06. The stock has 6 warning signs investors should review. Among 274 Healthcare Providers & Services companies, Cross Country Healthcare ranks better than 76.64% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:XXY vs SRTA, CYH, AUNA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Cross Country Healthcare's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cross Country Healthcare Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cross Country Healthcare's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Cross Country Healthcare's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cross Country Healthcare (FRA:XXY) has a Buyback Yield % of 1.37 as of Jul. 25, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cross Country Healthcare and its competitors. This is 63% below median its historical median of 3.67. Over the past decade, Cross Country Healthcare's Buyback Yield % has ranged from 0.09 to 9.19. According to the industry distribution chart, Cross Country Healthcare ranks #64 out of 274 companies in the Healthcare Providers & Services industry, placing it in the top 23.4%.
Is Cross Country Healthcare's Buyback Yield % too high?
Cross Country Healthcare's current Buyback Yield % of 1.37 is 63% below median its 10-year median of 3.67. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 9.19. Based on the distribution chart, Cross Country Healthcare ranks #64 out of 274 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Cross Country Healthcare has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Cross Country Healthcare's Buyback Yield % compare to SRTA and CYH?
According to the Healthcare Providers & Services industry distribution chart, Cross Country Healthcare ranks #64 out of 274 companies for Buyback Yield %. This places Cross Country Healthcare in the top 23% of its industry — outperforming the majority of peers. Historically, Cross Country Healthcare's own Buyback Yield % has ranged from 0.09 to 9.19 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Cross Country Healthcare and its competitors. Cross Country Healthcare's current Buyback Yield % is 1.37, which is 63% below median its own 10-year median of 3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cross Country Healthcare stock overvalued right now?
Cross Country Healthcare (FRA:XXY) has a current Buyback Yield % of 1.37. The stock's GF Value™ is €9.06, compared to a current price of €11.50 — trading 26.9% above its estimated fair value. The current Buyback Yield % is 1.37, which is 63% below median its 10-year median of 3.67. Cross Country Healthcare's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Cross Country Healthcare (FRA:XXY), the current Buyback Yield % is 1.37 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cross Country Healthcare (FRA:XXY) Overvalued in 2026?
Based on GuruFocus' analysis, Cross Country Healthcare stock appears to be overvalued.
The current stock price of €11.50 is trading 26.9% above its estimated GF Value™ of €9.06.
Key valuation signals for FRA:XXY:
Buyback Yield %: 1.37 (63% below median its 10-year median of 3.67)
GF Value™: €9.06 vs. price of €11.50 (26.9% above fair value)
No single metric tells the full story. See the FRA:XXY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
56GF Score
Get the complete analysis for FRA:XXY
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XXY has been successfully added to your 
